Selection of an ACE inhibitor in clinical practice
Currently, ACE inhibitors are considered to be the gold standard in the treatment of cardiovascular diseases. They all have cardio-, vaso- and nephroprotective and positive metabolic effects; however, despite the large number of the so-called class effects, the drugs differ in pharmacokinetic charac...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2014-12-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/693 |
| _version_ | 1797841229084360704 |
|---|---|
| author | OD Ostroumova ML Maksimov OV Dralova AS Yermolayeva |
| author_facet | OD Ostroumova ML Maksimov OV Dralova AS Yermolayeva |
| author_sort | OD Ostroumova |
| collection | DOAJ |
| description | Currently, ACE inhibitors are considered to be the gold standard in the treatment of cardiovascular diseases. They all have cardio-, vaso- and nephroprotective and positive metabolic effects; however, despite the large number of the so-called class effects, the drugs differ in pharmacokinetic characteristics which determine the difference in their clinical effects. The article is about choosing the optimal drug from the group of ACE inhibitors in clinical practice. |
| first_indexed | 2024-04-09T16:28:47Z |
| format | Article |
| id | doaj.art-918ea0bba61c47ce91ed7ea92b759d4d |
| institution | Directory Open Access Journal |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| last_indexed | 2024-04-09T16:28:47Z |
| publishDate | 2014-12-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| series | Медицинский совет |
| spelling | doaj.art-918ea0bba61c47ce91ed7ea92b759d4d2023-04-23T06:57:13ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902014-12-01012869110.21518/2079-701X-2014-12-86-91693Selection of an ACE inhibitor in clinical practiceOD Ostroumova0ML Maksimov1OV Dralova2AS Yermolayeva3Moscow State University of Medicine and Dentistry named after AI Evdokimovthe Sechenov First Moscow State Medical Universitythe Sechenov First Moscow State Medical Universitythe Sechenov First Moscow State Medical UniversityCurrently, ACE inhibitors are considered to be the gold standard in the treatment of cardiovascular diseases. They all have cardio-, vaso- and nephroprotective and positive metabolic effects; however, despite the large number of the so-called class effects, the drugs differ in pharmacokinetic characteristics which determine the difference in their clinical effects. The article is about choosing the optimal drug from the group of ACE inhibitors in clinical practice.https://www.med-sovet.pro/jour/article/view/693артериальная гипертензиясердечная недостаточностьингибиторы апффозиноприлhypertensionheart failureace inhibitorsfosinopril |
| spellingShingle | OD Ostroumova ML Maksimov OV Dralova AS Yermolayeva Selection of an ACE inhibitor in clinical practice Медицинский совет артериальная гипертензия сердечная недостаточность ингибиторы апф фозиноприл hypertension heart failure ace inhibitors fosinopril |
| title | Selection of an ACE inhibitor in clinical practice |
| title_full | Selection of an ACE inhibitor in clinical practice |
| title_fullStr | Selection of an ACE inhibitor in clinical practice |
| title_full_unstemmed | Selection of an ACE inhibitor in clinical practice |
| title_short | Selection of an ACE inhibitor in clinical practice |
| title_sort | selection of an ace inhibitor in clinical practice |
| topic | артериальная гипертензия сердечная недостаточность ингибиторы апф фозиноприл hypertension heart failure ace inhibitors fosinopril |
| url | https://www.med-sovet.pro/jour/article/view/693 |
| work_keys_str_mv | AT odostroumova selectionofanaceinhibitorinclinicalpractice AT mlmaksimov selectionofanaceinhibitorinclinicalpractice AT ovdralova selectionofanaceinhibitorinclinicalpractice AT asyermolayeva selectionofanaceinhibitorinclinicalpractice |